Home Necrotizing enterocolitis following intensive phototherapy in full-term newborns – is there a possible association?
Article Publicly Available

Necrotizing enterocolitis following intensive phototherapy in full-term newborns – is there a possible association?

  • Arieh Riskin EMAIL logo , Amir Kugelman and David Bader
Published/Copyright: May 23, 2015

Abstract

Background: Necrotizing enterocolitis is rare in full-term infants, and is currently not considered a known complication of phototherapy.

Highlights: Three cases of necrotizing enterocolitis in full-term babies possibly associated to intensive phototherapy for treatment of early neonatal hyperbilirubinemia due to isoimmune hemolytic disease of the newborn.

Conclusions: Although rare, the association between occurrences of necrotizing enterocolitis in full-term newborn infants and intensive phototherapy merits caution and clinical awareness to such possible complication. Presumptive explanation is that intensive phototherapy causes marked vasodilataion in the skin that may result in decreased perfusion of the intestine leading to ischemia and necrotizing enterocolitis. This calls for further studies to investigate the effects of phototherapy on the vascular bed in the gut and other vital organs that could have clinical implications.

Introduction

The American Academy of Pediatrics (AAP) Subcommittee on Hyperbilirubinemia issued clinical practice guidelines on the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [1]. These guidelines that are widely accepted worldwide, include a recommendation to provide intensive phototherapy with high levels of irradiance in the 430- to 490-nm band (usually up to 30 μW/cm2 per nm or even higher) delivered to as much of the infant’s surface area for the treatment of significant neonatal hyperbilirubinemia.

We present three cases of full-term newborns who were treated by intensive phototherapy, and developed necrotizing enterocolitis (NEC), that is currently not considered as a complication of phototherapy, and raise the possibility of an association between them. The hospital’s Ethics Committee waived the need for institutional review board (IRB) approval or parental consent, because the following descriptions do not include any identifying details of the infants discussed.

Presentation of the cases

Case 1

A full-term (42 weeks’ gestation) large for gestational age (LGA) (birth-weight 4320 g) male infant was born by cesarean delivery due to non-progressive labor and non-reassuring fetal heart monitoring. Apgar scores were 7 and 10 (at 1 and 5 min). The baby was vigorous, physical examination was normal, and blood glucose and CBC were normal. There were no risk factors for infection. He developed an early and rapidly progressive indirect neonatal hyperbilirubinemia because of isoimmune hemolytic disease due to AO incompatibility reaction with direct reacting antiglobulin (Coombs) test. Phototherapy was started at the age 2 h, and was increased to maximal intensive phototherapy (30 μW/cm2) at the age of 16 h. He was also given intravenous gamma-globulin (IVIG) (0.75 g/kg) at the age of 24–26 h for rising total serum bilirubin (TSB) levels under intensive phototherapy. Maximal TSB was 14.2 mg/dL at the age of 24 h. At the age of 28 h, TSB levels started to decline. Phototherapy was gradually decreased and was discontinued at the end of the 2nd day of life. He was fed term infant formula. On the 3rd day the baby became tachypneic, and looked sick, and had a full sepsis workup and antibiotics. All cultures were negative. On the 5th day of life he developed symptoms and signs consistent with NEC with abdominal distention and pneumatosis intestinalis (mostly colonic) on abdominal X-ray. He had no bloody stools and stool cultures were negative. Although his reticulocyte count was high (up to 21% due to the AO incompatibility and isoimmune hemolysis, he was not anemic at this stage (hematocrit of 41–42%). Anemia (27–30% hematocrit) appeared only later at the age of 10–15 days. He was treated by withholding feeds, parenteral nutrition, antibiotics, and supportive treatment for 10 days, but on the 15th day upon trial to resume feeds, he developed symptoms and signs consistent with large bowel obstruction. He was operated, and whole colonic inflammation, consistent with the diagnosis of NEC with stricture in the sigmoid colon, was found. The stricture was resected and colostomy was left. He recovered well after surgery, feeds were well tolerated, and he was discharged home on day of life 37.

Case 2

A full-term (41 weeks’ gestation) appropriate for gestational age (AGA) (birth-weight 3140 g) female infant was born by vaginal delivery. There were no risk factors for infection. She developed an early and rapidly progressive indirect neonatal hyperbilirubinemia because of isoimmune hemolytic disease due to AO incompatibility reaction with direct reacting Coombs test, and treatment with phototherapy was started at the age of 3 h. Maximal TSB was 11.2 mg/dL at the age of 11.5 h. Under intensive phototherapy (32 μW/cm2), TSB levels started to decline at the age of 14 h. Phototherapy was gradually decreased and was discontinued on the end of the 3rd day. She was feeding on her own mother’s milk. On the 2nd day of life, the baby developed abdominal distention and vomiting without bloody stools, and serial radiographs of the abdomen were consistent with pneumatosis intestinalis (in the right and left upper quadrants that were suspected to be colonic) indicative of NEC. Her hematocrit was 47–48% without evidence of anemia or severe hemolysis. She was treated medically with antibiotics and cessation of feeding for 7 days. She recovered well, feedings were tolerated, and she was discharged home on the 14th day of life.

Case 3

A full-term (41+2/7 weeks’ gestation) AGA (birth-weight 3450 g) male infant was born by cesarean delivery due to non-reassuring fetal heart monitoring (with cord pH 7.10, BE −12.3). Amniotic fluids were meconium stained upon rupture. The baby required short resuscitation after delivery, but recovered within 8 min, and was transferred to the neonatal unit breathing spontaneously without any need for oxygen or other support. His Apgar scores were 1, 3, 8, and 10 at 1, 5, 10, and 15 min, respectively. He had no evidence for meconium aspiration or hypoxic ischemic encephalopathy, and he did not suit the criteria for neonatal asphyxia. There were no risk factors for infection. He developed an early and rapidly progressive indirect neonatal hyperbilirubinemia because of isoimmune hemolytic disease due to AO incompatibility reaction with direct Coombs test and glucose-6-phosphatase dehydrogenase (G6PD) deficiency. Treatment with phototherapy was started at the age of 9 h. Under intensive phototherapy TSB levels declined. Phototherapy was discontinued on the 2nd day of life. He was fed term infant formula. On the 3rd day of life the baby presented with loss of appetite, bloody stools, and abdominal tenderness. Stool cultures were negative. Clinical and radiographic signs were consistent with Bell’s stage II NEC with pneumatosis intestinalis (in the right abdomen that looked mostly in the small bowel, possibly illeal up to the junction with the cecum). Although he had no anemia at the initiation of his abdominal symptoms (hematocrit 43% with 17% reticulocytes due to isoimmune hemolysis), his hematocrit rapidly decreased to 36% within a day, and later on dropped to 27%. He was treated medically with antibiotics and cessation of feeding for 7 days, and recovered well. Feedings were tolerated without evidence of intestinal inflammation or obstruction. He was discharged home on the 28th day of life.

Discussion

NEC is currently not considered a possible complication of phototherapy. The appearance of cases of newborns that were treated by intensive phototherapy and developed NEC that is not frequent in full-term babies, raised the question whether there may be an association between NEC and treatment with intensive phototherapy.

All three cases had isoimmunization with positive direct Coombs test causing significant jaundice with rapidly rising bilirubin levels mandating intensive phototherapy. The only two factors constant among these three cases are isoimmunization with rapid increase in bilirubin levels and the use of intensive phototherapy. In the following paragraph we will try to suggest an association between NEC and intensive phototherapy, while trying to address why the other etiologic possibilities related to isoimmune hyperbilirubinemia and other treatments given seem less likely, although not excluded.

NEC was previously described in association to exchange transfusion, but not phototherapy. Yet it was shown that postprandial increase in perfusion of the gut does not occur or is reduced under phototherapy [2]. The presumptive explanation is that intensive phototherapy causes marked vasodilataion in the skin, resulting in decreased perfusion of the intestine, ischemia, and NEC. Possibly, increased enteral feeds consumed by many newborns under intensive phototherapy, that by itself already predisposes the gut to relative ischemia, create imbalance between supply and demand of perfusion to the gut, which might lead to NEC. Another possible explanation is related to a study that showed that abdominal exposure to phototherapy had been associated with increased neonatal intestinal apoptosis in an animal model [3]. Neutrophil function is also altered by phototherapy [4], and it is well established that neutrophils play a major role in the pathogenesis of NEC. Another possible explanation may be the marked decrease in bilirubin, which is a known antioxidant, because of the intensive photoisomerisation that increases the risk for oxygen-radical-mediated diseases, such as NEC. The role of the hemolytic disease as a possible contributing factor to NEC in these babies cannot be excluded, although previously described only in Rh incompatibility [5], and without a good pathophysiological mechanism to explain this association. The infants in the cases presented did not have anemia secondary to the hemolysis before the appearance of NEC, thus a possible explanation relating anemia to decreased tissue oxygenation leading to NEC is less likely here. The use of IVIG in severe isoimmune hemolytic jaundice caused by Rh or ABO incompatibility in infants who did not sufficiently respond to phototherapy was also associated with increased incidence of NEC, although this might be applicable to case 1 only [6–8]. Although it may be argued that transfusion played a role in the etiology of NEC in case 1, this is highly unlikely, because he was not transfused with RBCs before he developed NEC. He also did not have bloody stools or eosinophilia that is related to NEC from this etiology [9]. It may be argued that case 3 had predisposition to NEC because of perinatal depression; however, he had no other signs consistent with such a possibility. Only case 3 also had bloody stools but the rest of his clinical presentation did not resemble atopic enteropathy. None of our infants had eosinophilia, which also disputes against this differential diagnosis [9].

The three cases hereby presented occurred over 6 years period. To our estimate this translates to a very low incidence of <0.1% of the term newborn infants undergoing intensive phototherapy for severe early hemolytic neonatal jaundice. Although rare, this occurrence of NEC in full-term newborn infants in relation to intensive phototherapy merits some caution and mainly clinical awareness to such possible complication of phototherapy.

Following the principles of Sir Bradford Hill on the inference of causality [10], we can say that although we have shown relationship in time (temporality), possible coherence of evidence and analogy, and have suggested an explanation with biological plausibility, the strength of the association between NEC and intensive phototherapy is relatively low, specificity is hard to demonstrate and we have no data or experimental proof to support consistency or biological gradient (dose-response relationship).

Although we cannot establish any causative relationship, the close temporal relationship between intensive phototherapy and the clinical presentation of NEC along with the suggested causative mechanism related to decreased perfusion to the gut under phototherapy makes this association very plausible. We hereby call for research studies on the possible effects of phototherapy on the vascular bed in the gut and other vital organs that may interfere with perfusion, thus having clinical implications.


Corresponding author: Arieh Riskin, MD, Department of Neonatology, Bnai Zion Medical Center, 47 Golomb Street, POB 4940, Haifa 31048, Israel, Tel.: +972-4-835-9063/ 972-50-626-7330, Fax: +972-4-835-9206, E-mail:

References

[1] Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.10.1542/peds.114.1.297Search in Google Scholar

[2] Yao AC, Martinussen M, Johansen OJ, Brubakk AM. Phototherapy-associated changes in mesenteric blood flow response to feeding in term neonates. J Pediatr. 1994;124:309–12.10.1016/S0022-3476(94)70325-6Search in Google Scholar

[3] Tanaka K, Hashimoto H, Tachibana T, Ishikawa H, Ohki T. Apoptosis in the small intestine of neonatal rat using blue light-emitting diode devices and conventional halogen-quartz devices in phototherapy. Pediatr Surg Int. 2008;24:837–42.10.1007/s00383-008-2170-4Search in Google Scholar PubMed

[4] Morgan MC, Rashid RM. The effect of phototherapy on neutrophils. Int Immunopharmacol. 2009;9:383–8.10.1016/j.intimp.2009.02.001Search in Google Scholar PubMed

[5] Roig JC, Burchfield DJ. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases. J Perinatol. 1994;14:201–3.Search in Google Scholar

[6] Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics. 2010;25:139–44.10.1542/peds.2009-0676Search in Google Scholar PubMed

[7] Kara S, Ulu-ozkan H, Yilmaz Y, Arikan FI, Dilmen U, Bilge YD. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease. J Coll Physicians Surg Pak. 2013;23:598–600.Search in Google Scholar

[8] Navarro M, Negre S, Matoses ML, Golombek SG, Vento M. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr. 2009;98:1214–7.10.1111/j.1651-2227.2009.01279.xSearch in Google Scholar PubMed

[9] Christensen RD, Lambert DK, Gordon PV, Baer VL, Gerday E, Henry E. Neonates presenting with bloody stools and eosinophilia can progress to two different types of necrotizing enterocolitis. J Perinatol. 2012;32:874–9.10.1038/jp.2011.163Search in Google Scholar PubMed

[10] Doll R. Sir Austin Bradford Hill and the progress of medical science. Br Med J. 1992;305:1521–6.10.1136/bmj.305.6868.1521Search in Google Scholar PubMed PubMed Central

  1. The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2015-01-29
Accepted: 2015-05-04
Published Online: 2015-05-23
Published in Print: 2015-09-01

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Case reports – Obstetrics
  3. Minimally invasive procedure for type II canal defect caesarean scar pregnancy with cardiac activity and high hCG titres at 8+2 weeks of gestation
  4. Rare causes of acute abdomen in pregnancy: “ultrasound to the rescue”. A review of two cases
  5. Enlargement of hepatic hemangioma in successive pregnancies
  6. Misdiagnosis of macroamylasemia in pregnancy as pancreatitis
  7. An advanced cervical ectopic pregnancy
  8. Multidisciplinary management of giant genital tract venous malformations during pregnancy: case report and review of the literature
  9. Acute uterine rupture in spontaneous term labour in a healthy primigravida: case report and review of the literature
  10. Massive ascites in a patient with preeclampsia
  11. Loeys-Dietz syndrome in pregnancy
  12. Prenatal diagnosis of periventricular venous infarction in utero: a case with hereditary protein C deficiency
  13. Case reports – Fetus
  14. Placental chorioangioma presenting prenatal hemolytic anemia and consumption coagulopathy: a case report
  15. Management of fetal ovarian cyst using in utero aspiration
  16. A case of fetal cardiac rupture diagnosed by postmortem magnetic resonance image
  17. Unusual presentation of fetus in fetu in triplet pregnancy mimicking abdominal wall defect
  18. Acral necrosis and upper brachial plexus palsy after prenatal fetal thrombosis
  19. Prenatal diagnosis of a giant fetal hepatic hemangioma: a case report
  20. Prenatal diagnosis and outcomes of fetal cardiac rhabdomyomas: evaluation of seven cases
  21. Case reports – Newborn
  22. Polythelia and associated hydronephrosis: a case report in neonatal age
  23. Necrotizing enterocolitis following intensive phototherapy in full-term newborns – is there a possible association?
  24. A case of neonatal toxic shock syndrome-like exanthematous disease concurrent with maternal toxic shock syndrome
Downloaded on 29.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/crpm-2015-0006/html?lang=en&srsltid=AfmBOoozGMZT1Cz6bfkeQyQgGNmnrpGhL1QFjVF7alDUEVOXNBQMqh10
Scroll to top button